Exploring the Contribution of Myelin Content in Normal Appearing White Matter to Cognitive Outcomes in Cerebral Small Vessel Disease.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2021
Historique:
pubmed: 2 2 2021
medline: 14 9 2021
entrez: 1 2 2021
Statut: ppublish

Résumé

Myelin damage is a salient feature in cerebral small vessel disease (cSVD). Of note, myelin damage extends into the normal appearing white matter (NAWM). Currently, the specific role of myelin content in cognition is poorly understood. The objective of this exploratory study was to investigate the association between NAWM myelin and cognitive function in older adults with cSVD. This exploratory study included 55 participants with cSVD. NAWM myelin was measured using myelin water imaging and was quantified as myelin water fraction (MWF). Assessment of cognitive function included processing speed (Trail Making Test Part A), set shifting (Trail Making Test Part B minus A), working memory (Verbal Digit Span Backwards Test), and inhibition (Stroop Test). Multiple linear regression analyses assessed the contribution of NAWM MWF on cognitive outcomes controlling for age, education, and total white matter hyperintensity volume. The overall alpha was set at ≤0.05. After accounting for age, education, and total white matter hyperintensity volume, lower NAWM MWF was significantly associated with slower processing speed (β  = -0.29, p = 0.037) and poorer working memory (β= 0.30, p = 0.048). NAWM MWF was not significantly associated with set shifting or inhibitory control (p > 0.132). Myelin loss in NAWM may play a role in the evolution of impaired processing speed and working memory in people with cSVD. Future studies, with a longitudinal design and larger sample sizes, are needed to fully elucidate the role of myelin as a potential biomarker for cognitive function.

Sections du résumé

BACKGROUND
Myelin damage is a salient feature in cerebral small vessel disease (cSVD). Of note, myelin damage extends into the normal appearing white matter (NAWM). Currently, the specific role of myelin content in cognition is poorly understood.
OBJECTIVE
The objective of this exploratory study was to investigate the association between NAWM myelin and cognitive function in older adults with cSVD.
METHODS
This exploratory study included 55 participants with cSVD. NAWM myelin was measured using myelin water imaging and was quantified as myelin water fraction (MWF). Assessment of cognitive function included processing speed (Trail Making Test Part A), set shifting (Trail Making Test Part B minus A), working memory (Verbal Digit Span Backwards Test), and inhibition (Stroop Test). Multiple linear regression analyses assessed the contribution of NAWM MWF on cognitive outcomes controlling for age, education, and total white matter hyperintensity volume. The overall alpha was set at ≤0.05.
RESULTS
After accounting for age, education, and total white matter hyperintensity volume, lower NAWM MWF was significantly associated with slower processing speed (β  = -0.29, p = 0.037) and poorer working memory (β= 0.30, p = 0.048). NAWM MWF was not significantly associated with set shifting or inhibitory control (p > 0.132).
CONCLUSION
Myelin loss in NAWM may play a role in the evolution of impaired processing speed and working memory in people with cSVD. Future studies, with a longitudinal design and larger sample sizes, are needed to fully elucidate the role of myelin as a potential biomarker for cognitive function.

Identifiants

pubmed: 33523006
pii: JAD201134
doi: 10.3233/JAD-201134
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-101

Auteurs

Elizabeth Dao (E)

Department of Physical Therapy, University of British Columbia (UBC), Vancouver, Canada.
Djavad Mowafaghian Centre for Brain Health, UBC, Vancouver, Canada.
Centre for Hip Health and Mobility, Vancouver Coastal Health Research Institute, Vancouver, Canada.

Roger Tam (R)

Djavad Mowafaghian Centre for Brain Health, UBC, Vancouver, Canada.
Department of Radiology, UBC, Vancouver, Canada.
School of Biomedical Engineering, UBC, Vancouver, Canada.

Ging-Yuek R Hsiung (GR)

Djavad Mowafaghian Centre for Brain Health, UBC, Vancouver, Canada.
Division of Neurology, UBC Hospital, Vancouver, Canada.

Lisanne Ten Brinke (L)

Department of Physical Therapy, University of British Columbia (UBC), Vancouver, Canada.
Djavad Mowafaghian Centre for Brain Health, UBC, Vancouver, Canada.
Centre for Hip Health and Mobility, Vancouver Coastal Health Research Institute, Vancouver, Canada.

Rachel Crockett (R)

Department of Physical Therapy, University of British Columbia (UBC), Vancouver, Canada.
Djavad Mowafaghian Centre for Brain Health, UBC, Vancouver, Canada.
Centre for Hip Health and Mobility, Vancouver Coastal Health Research Institute, Vancouver, Canada.

Cindy K Barha (CK)

Department of Physical Therapy, University of British Columbia (UBC), Vancouver, Canada.
Djavad Mowafaghian Centre for Brain Health, UBC, Vancouver, Canada.
Centre for Hip Health and Mobility, Vancouver Coastal Health Research Institute, Vancouver, Canada.

Youngjin Yoo (Y)

Department of Radiology, UBC, Vancouver, Canada.

Walid Al Keridy (W)

Djavad Mowafaghian Centre for Brain Health, UBC, Vancouver, Canada.
Division of Neurology, UBC Hospital, Vancouver, Canada.
Department of Medicine, King Saud University, College of Medicine, Riyadh, Saudi Arabia.

Stephanie H Doherty (SH)

Department of Physical Therapy, University of British Columbia (UBC), Vancouver, Canada.
Djavad Mowafaghian Centre for Brain Health, UBC, Vancouver, Canada.
Centre for Hip Health and Mobility, Vancouver Coastal Health Research Institute, Vancouver, Canada.

Cornelia Laule (C)

Department of Radiology, UBC, Vancouver, Canada.
Department of Pathology and Laboratory Medicine, UBC, Vancouver, Canada.
Department of Physics and Astronomy, UBC, Vancouver, Canada.
International Collaboration on Repair Discoveries, Vancouver, Canada.

Alex L MacKay (AL)

Department of Radiology, UBC, Vancouver, Canada.
UBC MRI Research Centre, UBC, Vancouver, Canada.

Teresa Liu-Ambrose (T)

Department of Physical Therapy, University of British Columbia (UBC), Vancouver, Canada.
Djavad Mowafaghian Centre for Brain Health, UBC, Vancouver, Canada.
Centre for Hip Health and Mobility, Vancouver Coastal Health Research Institute, Vancouver, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH